• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Cala launches next-gen wearable for essential tremor, Parkinson’s therapy

Cala launches next-gen wearable for essential tremor, Parkinson’s therapy

June 14, 2023 By Sean Whooley

Cala Health kIQ wearable tremor therapy
The Cala kIQ wearable. [Image from Cala’s website]
Cala announced today that it launched its next-generation Cala kIQ system, a wearable device that delivers therapy for neurological disorders.

The San Mateo, California-based company develops the Cala Trio device for transcutaneous afferent patterned stimulation (TAPS) therapy. Cala designed the Trio device for treating tremor. Its kIQ system delivers therapy for action hand termor relief in those with essential tremor and Parkinson’s disease.

Cala kIQ also delivers TAPS therapy, validated by large clinical studies and real-world evidence. It enables on-demand, comfortable, at-home therapy for ease of use and management of action hand tremors. This type of tremor occurs when a patient undergoes intentional movement or posture, Cala said.

“At Cala, we’ve always been committed to expanding patient access and accelerating innovation in TAPS therapy for indications beyond essential tremor,” said Renee Ryan, CEO at Cala. “By expanding into Parkinson’s disease, we are now able to bring this powerful treatment to additional patients who suffer from action hand tremors.”

More about Cala kIQ

According to the company, treatment for these conditions historically came through medications or even surgery. Cala kIQ offers a non-invasive, non-pharmacologic solution with minimal side effects.

The system measures each patient’s unique tremor physiology and individualizes a stimulation pattern for tremor relief. Cala said it designed the system for ease of use for patients, plus easy management for clinicians. On-demand therapy comes through a wrist-worn wearable. The system also offers online data insights through the MyCala.com patient portal. This enables patients to see therapy session results over time and choose to share with providers to adjust treatment plans.

“Current research shows that tremors can severely impact patients’ mental health and activities of daily living,1 which are essential tasks such as holding a cup, unlocking a door, or dialing a phone,” said Dr. Pravin Khemani. “There’s a real need for patient populations who suffer from action hand tremors to have an effective, safe option when it comes to managing their symptoms – which is exactly where TAPS therapy can come in and make a significant difference.”

Filed Under: Business/Financial News, Featured, Health Technology, Neurological, Neuromodulation/Neurostimulation, News Well Tagged With: Cala Health

More recent news

  • Siemens Healthineers debuts Accela single-breath radiotherapy system
  • GE HealthCare hires chief AI officer from Medtronic
  • Former Teleflex CEO to lead Inspire competitor Nyxoah
  • Retired Stryker leader Tim Scannell dies at 62
  • HighLife raises more than $90M to advance its TMVR system

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy